Health Care/Hospital

111, Inc. Announces Establishment of the Special Committee

SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairma...

2026-09-28 16:30 3822

SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients

TOKYO and BOSTON, Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), announced that it has been awarded a grant of approximately 6 billion yen over five years by the Japan Agency f...

2026-09-28 14:00 2292

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

HONG KONG, Sep. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific...

2026-09-28 10:05 3524

Metaverse Lab-XR: Virtual Lab Builds Diagnostic and Teamwork Skills for Medical Technology Students

A Chula Medical Technology lecturer has developed Metaverse Lab-XR , an innovative virtual laboratory that allows students to practice lab procedures and develop the soft skills needed for real-world work in hospitals, pr...

2026-09-28 10:00 2452

Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC

SAN FRANCISCO and SUZHOU, China, Sept. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabo...

2026-09-28 08:00 2320

2026 IMS | IASO Bio Presented FUCASO China Real-World Data

--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients with relapsed/refractory plasma cell neoplasms,FUCASO achieved a 95.9% objective response rate, a 77.2% CR/sCR rate, and a 94.1% MRD negativity rate --- with median PFS and OS not yet reached (12-mo...

2026-09-27 11:16 2580

2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206

— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion of IASO206 generated functional BCMA CAR-T cells in vivo without lymphodepleting chemotherapy. The study demonstrated a 90% objective response rate and a 90% MRD negativity rate in a popula...

2026-09-27 11:03 7822

Second NRF2 Degrader Enters Clinical Development: Nutshell Therapeutics' NTS231 Received FDA IND Clearance

SHANGHAI, Sept. 25, 2026 /PRNewswire/ -- Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, announced FDA IND clearance for NTS231, a covalent allosteric molecular glue degrader of NRF2, to launch cli...

2026-09-25 20:00 9673

Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters

* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...

2026-09-25 15:52 3132

Greenfield Dental Market Insights: Rising Dental Costs Push Thousands of Western Patients to Vietnam

HANOI, Vietnam, Sept. 25, 2026 /PRNewswire/ -- Greenfield Dental has recorded a significant surge in international patient volume with over 300% growth since 2025, reflecting Vietnam's emergence as a premier dental tourism destination and Greenfield's growing reputation.

2026-09-25 14:17 2284

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/...

2026-09-25 13:10 2463

XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain

* This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's AI and robotics-driven drug discovery platform and its transition to a clinical-stage organization. * Preclinical data demonstrate sub-nanomol...

2026-09-25 08:30 3895

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...

2026-09-25 01:44 2505

Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs

SHANGHAI and SHAOXING, China, Sept. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") and NovoCodex Biopharmaceuticals Co., Ltd. ("NovoCodex") jointlyannounced that the two companies have formally entered into a strategic collaboration agreement. The partnership will foc...

2026-09-24 22:00 4137

MSF Shares Experience in Delivering Cancer Care to Women in Humanitarian Crises at World Cancer Congress 2026

HONG KONG, Sept. 24, 2026 /PRNewswire/ -- Speaking for the first time at the World Cancer Congress in Hong Kong this week, Médecins Sans Frontières/Doctors Without Borders (MSF), an international medical humanitarian organisation, will share its experiences from its cancer programmes in Mali and ...

2026-09-24 21:24 2988

From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026

ZEISS Medical Technology advances its ZEISS Retina Workflow

2026-09-24 21:00 2646

Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology

WILMINGTON, Del., Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member of the Roche Group, to discover and develop multiple therapeutic bispecific antibody programs ...

2026-09-24 19:00 1892

Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026

BEIJING, Sept. 24, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended June 30, 2026. Highlights for the Quarter Ended June 30, 2026 * Transaction volume was 21,899 ...

2026-09-24 16:20 4273

Carestream Healthcare International Launches STARVIEW Digital Radiography System

SHANGHAI, Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of theCARESTREAM STARVIEW Digital Radiography System, a focused, floor-mounted DR room designed for routine radiographic imaging. Healthcare facilities modernize radiography for different reasons, fr...

2026-09-24 14:07 1704

After the Weight Comes Off: Treating GLP-1-Related Skin Laxity with Sofwave

SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Across cosmetic and dermatology clinics, a new patient profile is becoming increasingly familiar. Someone who has lost a significant amount of weight on a GLP-1 medication and is thrilled with the overall result but is now booking a consultation for somethin...

2026-09-24 08:40 1573
12345678 ... 846